Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Diabetes UK reported that more than 12 million people in the UK are now living with diabetes or prediabetes. The total includes 4·6 million with diabetes (90% type 2 diabetes, 8% type 1 diabetes, and ...

Ozempic and similar drugs are popular with consumers for their weight-loss properties, but a new study suggests they could ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

Past studies have found a potential link between semaglutide and the eye condition called nonarteritic anterior ischemic optic neuropathy (NAION). A recently-published investigatory review reports ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

What Is the Maximum Semaglutide Dose for Weight Loss? The maximum semaglutide dose for weight loss is 2.4 milligrams (mg) per week. Your healthcare provider will start you on a lower weekly dose ...

- Data adds to growing body of evidence of the RaniPill ® platform's potential to enable oral delivery of multiple obesity treatments - - Phase 1 study for RT-114, an oral GLP-1/GLP-2 dual agonist for ...